Position in RPRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$19,283
+$7,846 QoQ
Shares Held
402
+35.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cornerstone Planning Group LLC holds $285,266 across 38 Biotechnology names. RPRX ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
116 | $51,798 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100 | $33,087 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35 | $27,042 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
402 | $19,283 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
194 | $18,866 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
287 | $18,548 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
300 | $14,271 | |
| 8 | ARGX |
Argenx SE
|
15 | $10,953 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,283 | 402 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,437 | 296 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $18,733 | 531 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,503 | 125 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,113 | 100 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,198 | 47 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||